Clinical management of lung cancer patients during the outbreak of 2019 novel coronavirus disease (Covid-19)

Chinese Journal of Lung Cancer

Volumn 23, Issue 3, 2020, Pages 136-141

  Xu, Yan ^a   Liu, Hongsheng ^a   Hu, Ke ^a   Wang, Mengzhao ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

2019 novel coronavirus disease; Lung neoplasms; Patient management

Indexed keywords

ARTICLE; CANCER PATIENT; CHINA; CORONAVIRUS DISEASE 2019; EPIDEMIC; FEVER; HIGH RISK POPULATION; HUMAN; IMMUNE DEFICIENCY; INFECTION SENSITIVITY; LUNG CANCER; PATIENT CARE; RESPIRATORY TRACT DISEASE; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; BETACORONAVIRUS; CORONAVIRUS INFECTION; DISEASE PREDISPOSITION; IMMUNOCOMPROMISED PATIENT; LUNG TUMOR; PATHOGENICITY; PATIENT CARE PLANNING; RISK; VIRUS PNEUMONIA;

COVID-19; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2;

BETACORONAVIRUS; CHINA; CORONAVIRUS INFECTIONS; DISEASE OUTBREAKS; DISEASE SUSCEPTIBILITY; HUMANS; IMMUNOCOMPROMISED HOST; LUNG NEOPLASMS; PATIENT CARE PLANNING; PNEUMONIA, VIRAL; RISK;

EID: 85079789438     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2020.03.02     Document Type: Article

References (17)

1. Ren LL, Wang YM, Wu ZQ, et al. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J (Engl), 2020. doi: 10.1097/CM9.0000000000000722
2. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med, 2020, 382(8): 727-733. doi: 10.1056/NEJMoa2001017
3. Munster VJ, Koopmans M, van Doremalen N, et al. A novel coronavirus emerging in China-Key questions for impact assessment. N Engl J Med, 2020, 382(8): 692-694. doi: 10.1056/NEJMp2000929
4. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 2020, 579(7798): 270-273. doi: 10.1038/s41586-020-2012-7
5. Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet, 2020, pii: S0140-6736(20)30251-8. doi: 10.1016/S0140-6736(20)30251-8
6. Bonilla-Aldana DK, Quintero-Rada K, Montoya-Posada JP, et al. SARS-CoV, MERS-CoV and now the 2019-novel CoV: Have we investigated enough about coronaviruses?-A bibliometric analysis. Travel Med Infect Dis, 2020, 33: 101566. doi: 10.1016/j.tmaid.2020.101566
7. de Wit E, van Doremalen N, Falzarano D, et al. SA RS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol, 2016, 14(8): 523-534. doi: 10.1001/jama.2020.1585
8. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA, 2020. doi: 10.1001/jama.2020.1585
9. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020, 395(10223): 497-506. doi: 10.1016/S0140-6736(20)30183-5
10. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi, 2020, 41(2): 145-151 doi: 10.3760/ cma.j.issn.0254-6450.2020.02.003
11. Chan JF, Yuan S, Kok K H, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet, 2020, 395(10223): 514-523. doi: 10.1016/S0140-6736(20)30154-9
12. Liang W, Guan W, Chen R, et al. Cancer patients in SA RS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol, 2020, 21(3): 335-337. doi: 10.1016/S1470-2045(20)30096-6.
13. Kamboj M, Sepkowitz KA. Nosocomial infections in patients with cancer. Lancet Oncol, 20 09, 10(6): 589-597. doi: 10.1016/S1470-2045(09)70069-5
14. Lin L, Li TS. Interpretation of "Guidelines for the Diagnosis and Treatment of Novel Coronav ir us (2019-nCoV) Infection by the National Health Commission (Trial Version 5)". Zhonghua Yi Xue Za Zhi, 2020, 100(0): E001. doi: 10.3760/cma.j.issn.0376-2491.2020.0001
15. Guidelines for the Diagnosis and Treatment of Novel Coronavirus (2019-nCoV) Infection by the National Health Commission (Trial Version 6).
16. Hanania AN, Mainwaring W, Ghebre YT, et al. Radiation-induced lung injury: assessment and management. Chest, 2019, 156(1): 150-162. doi: 10.1016/j.chest.2019.03.033
17. Sears CR, Peikert T, Possick JD, et al. Knowledge gaps and research priorities in immune checkpoint inhibitor-related pneumonitis. Am J Respir Crit Care Med, 2019, 200(6): e31-e43. doi: 10.1164/